# 2-Hour Dispensing Evaluation of Samfilcon A Lenses With EPG01 Packaging Solution Compared to Commercially Available B+L Ultra Lenses

> **NCT05126953** · NA · COMPLETED · sponsor: **Bausch & Lomb Incorporated** · enrollment: 30 (actual)

## Conditions studied

- Contact Lens Wearer

## Interventions

- **DEVICE:** samfilcon A Lenses with EPG01 Packaging Solution
- **DEVICE:** Commercially Available B+L Ultra Lenses

## Key facts

- **NCT ID:** NCT05126953
- **Lead sponsor:** Bausch & Lomb Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-21
- **Primary completion:** 2021-09-23
- **Final completion:** 2021-09-23
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2025-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05126953

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05126953, "2-Hour Dispensing Evaluation of Samfilcon A Lenses With EPG01 Packaging Solution Compared to Commercially Available B+L Ultra Lenses". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05126953. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*